CYCLACEL PHARMACEUTICALS INC's ticker is CYCC and the CUSIP is 23254L306. A total of 19 filers reported holding CYCLACEL PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2016 | $41,000 | +28.1% | 106,036 | +63.2% | 0.00% | – |
Q4 2015 | $32,000 | -50.0% | 64,977 | -49.1% | 0.00% | – |
Q3 2015 | $64,000 | -37.9% | 127,546 | -1.1% | 0.00% | – |
Q2 2015 | $103,000 | -10.4% | 128,903 | +1.0% | 0.00% | – |
Q1 2015 | $115,000 | +12.7% | 127,578 | -12.0% | 0.00% | – |
Q4 2014 | $102,000 | -79.0% | 145,022 | -9.1% | 0.00% | – |
Q3 2014 | $485,000 | +15.5% | 159,529 | +16.6% | 0.00% | – |
Q2 2014 | $420,000 | -13.4% | 136,856 | +3.9% | 0.00% | – |
Q1 2014 | $485,000 | -17.8% | 131,658 | -10.4% | 0.00% | – |
Q4 2013 | $590,000 | -29.1% | 146,880 | -24.8% | 0.00% | – |
Q3 2013 | $832,000 | -28.1% | 195,309 | +2.3% | 0.00% | – |
Q4 2012 | $1,157,000 | – | 190,867 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Catalyst Capital Advisors LLC | 148,000 | $632,000 | 0.35% |
Invesco Private Capital | 116,316 | $496,000 | 0.05% |
TFS CAPITAL LLC | 97,688 | $416,000 | 0.02% |
A.R.T. Advisors, LLC | 35,067 | $149,000 | 0.01% |
Allianz Asset Management GmbH | 559,207 | $2,382,000 | 0.00% |
Tower Research Capital LLC (TRC) | 4,000 | $17,000 | 0.00% |
BARCLAYS PLC | 475,000 | $1,900,000 | 0.00% |
NOMURA HOLDINGS INC | 31,799 | $136,000 | 0.00% |
PRELUDE CAPITAL MANAGEMENT, LLC | 1,364 | $6,000 | 0.00% |
Virtu KCG Holdings LLC | 16,408 | $70,000 | 0.00% |